twitter logo youtube logo

Management of chronic heart failure


In Scotland the estimated prevalence of heart failure for all ages is 1.44% in men and 0.82% in women. This rises to 8.72% and 5.97% for men and women over the age of 75.

Remit and target users

This guideline provides evidence-based recommendations and best practice guidance on the management of patients with chronic heart failure. It provides recommendations on diagnosis, including natriuretic peptide testing, lifestyle, modification, pharmacological and interventional therapies, organisational planning and palliative care.

This guideline will be of interest to healthcare professionals involved in the management of patients with heart failure, including cardiac nurses, cardiac surgeons, cardiologists, general practitioners, pharmacists, psychologists, as well as patients, carers, voluntary organisations and policy makers.

How this guideline was developed

This guideline was developed using a standard methodology based on a systematic review of the evidence. Further details can be found in SIGN 50: A Guideline Developer’s Handbook .

Keeping up to date

This guideline was issued in 2016 and will be considered for review in three years. The review history, and any updates to the guideline in the interim period, will be noted in the review report.

If you are aware of any new evidence that would update this guideline please complete a change request form  and return to:

Current < 3 years


Full guideline (PDF)

Quick reference guide (PDF)

Annex 2 (PDF)

Annex 3 (PDF)

Annex 4 (PDF)

Annex 5 (PDF)

Annex 6 (PDF)

Apple app

Android app

Patient publications

Supporting material

Declarations of interest (PDF)

Search narrative (PDF)

Review report (PDF)

Copyright permission (PDF)

Contact us

SIGN 147, March 2016
ISBN 978 1 905813 43 6

guidelines international network logo


HIS Healthcare Improvement Scotland logo